Companies: 10,795·Total market cap: $144.5T
Neurocrine Biosciences, Inc.

Neurocrine Biosciences, Inc.

NBIXNASDAQHealthcare● Active
$163.02
$-0.86(-0.52%)
Market Cap$16.4B
P/E Ratio—
52W High$168
52W Low$122.14
Overview

Neurocrine Biosciences, Inc. (NBIX) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · NBIX · as of Feb 11, 2026

Latest filing snapshot

2,000
+200+11.11%vs prior year

Neurocrine Biosciences, Inc. (NBIX) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global
Total Employees
2,000
Change (1Y)
+200
Growth % (1Y)
+11.11%
Revenue / Employee
$1.43M
Net Income / Employee
$239.3K
Market Cap
$16.3B

NBIX Employee Count

1996 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2026-02-112,000+200+11.11%
2025-02-101,800+400+28.57%
2024-02-091,400+200+16.67%
2023-02-091,200+300+33.33%
2022-02-11900+55+6.51%
2021-02-05845+145+20.71%
2020-02-07700+115+19.66%
2019-02-08585+185+46.25%
2018-02-13400+204+104.08%
2017-02-14196+76+63.33%

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology
#SymbolCompanyEmployees
#1
ICON Public Limited Company
ICLR
ICON Public Limited Company
41,250#2
Dr. Reddy's Laboratories Limited
RDY
Dr. Reddy's Laboratories Limited
27,048#3
The Cooper Companies, Inc.
COO
The Cooper Companies, Inc.
16,000#4
Elanco Animal Health Incorporated
ELAN
Elanco Animal Health Incorporated
9,000#5
Hologic, Inc.
HOLX
Hologic, Inc.
7,063#6
Neurocrine Biosciences, Inc.
NBIX
Neurocrine Biosciences, Inc.YOU
2,000#7
Summit Therapeutics Inc.
SMMT
Summit Therapeutics Inc.
159
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · NBIX peer comparison

About NBIX employees

NBIX Employees · Headcount

Neurocrine Biosciences, Inc. (NBIX) employee data is sourced from the annual SEC 10-K filing. As of 2025, Neurocrine Biosciences, Inc. had 2,000 full-time employees globally. Full-time employees only. Global consolidated headcount.

Neurocrine Biosciences, Inc. employs 2,000 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $1.43M, reflecting the company's operational efficiency.

Neurocrine Biosciences, Inc.'s workforce increased by 200 (11.11%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Neurocrine Biosciences, Inc.'s revenue per employee of $1.43M positions it among the notable performers in the Biotechnology sector for operational efficiency.

RevenueFinancial statementsNet incomeSEC filingsPrice historyForecast & ratingsOwnershipEarnings

Frequently Asked Questions

NBIX Employees · 5 questions

As of the latest SEC 10-K filing (2025), Neurocrine Biosciences, Inc. had 2,000 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Neurocrine Biosciences, Inc. employee counthow many employees does Neurocrine Biosciences, Inc. haveNBIX total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-02-11